Ebara Corporation (TYO:6361)

G1 Therapeutics Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 12, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,353,344	1,136,543	770,714	434,508	589,791	321,398
Market Cap Growth	-18.45%	47.47%	77.38%	-26.33%	83.51%	1.62%
Enterprise Value	1,379,917	1,113,192	787,584	452,295	568,677	271,880
Last Close Price	2929.00	2434.67	1615.69	886.80	1154.75	593.25
PE Ratio	18.68	15.92	12.79	8.61	13.52	13.13
Forward PE	17.22	16.74	13.44	8.59	13.69	15.98
PS Ratio	1.53	1.31	1.01	0.64	0.98	0.61
PB Ratio	2.84	2.34	1.83	1.18	1.83	1.06
P/TBV Ratio	3.27	2.71	2.14	1.37	2.04	1.13
P/FCF Ratio	63.51	22.71	21.68	34.15	12.52	9.72
P/OCF Ratio	16.96	11.26	11.01	11.72	8.10	5.00
PEG Ratio	2.92	0.34	0.34	0.34	0.34	0.34
EV/Sales Ratio	1.56	1.28	1.04	0.66	0.94	0.52
EV/EBITDA Ratio	10.28	8.28	6.86	4.64	7.11	5.05
EV/EBIT Ratio	13.33	10.66	8.92	6.17	9.72	7.18
EV/FCF Ratio	64.76	22.24	22.16	35.55	12.07	8.22
Debt / Equity Ratio	0.39	0.31	0.35	0.32	0.35	0.25
Debt / EBITDA Ratio	1.39	1.12	1.26	1.22	1.40	1.39
Debt / FCF Ratio	8.62	3.01	4.09	9.38	2.38	2.26
Asset Turnover	0.91	0.90	0.87	0.88	0.90	0.86
Inventory Turnover	2.80	2.85	2.71	3.10	3.79	3.39
Quick Ratio	1.10	0.85	0.86	0.73	0.82	1.24
Current Ratio	1.67	1.74	1.79	1.57	1.53	1.70
Return on Equity (ROE)	16.55%	16.43%	16.13%	15.25%	14.83%	8.78%
Return on Assets (ROA)	6.48%	6.80%	6.34%	5.92%	5.46%	3.89%
Return on Capital (ROIC)	10.06%	10.86%	10.46%	9.94%	9.00%	6.31%
Return on Capital Employed (ROCE)	17.30%	17.40%	16.00%	16.00%	14.90%	10.40%
Earnings Yield	5.36%	6.28%	7.82%	11.62%	7.40%	7.61%
FCF Yield	1.57%	4.40%	4.61%	2.93%	7.99%	10.29%
Dividend Yield	1.92%	2.26%	2.83%	4.35%	2.82%	3.03%
Payout Ratio	35.04%	31.88%	31.42%	36.08%	23.97%	23.34%
Buyback Yield / Dilution	-0.04%	-0.10%	-0.15%	2.27%	1.33%	1.44%
Total Shareholder Return	1.86%	2.16%	2.69%	6.63%	4.16%	4.47%

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.